Trends in the prescription of drugs used for insomnia in Australian general practice, 2011-2018
CONCLUSION: Overall, BZD prescriptions in Australia declined from 2011-2018. However, the prescription of some of these drugs increased for patients with a recently recorded insomnia diagnosis. This is concerning because of potential adverse effects and risk of dependence.PMID:33950853 | DOI:10.3399/BJGP.2021.0054
Source: The British Journal of General Practice - Category: Primary Care Authors: Mumtaz Begum David Gonzalez-Chica Carla Bernardo Amelia Woods Nigel Stocks Source Type: research
More News: Alprazolam | Ambien | Australia Health | Diazepam | General Practices | Insomnia | Melatonin | Primary Care | Sleep Disorders | Sleep Medicine | Study | Temazepam | UK Health | Valium | Xanax